«The LINK - A dependent HIF1 signalizing cascade and the consequent effects
on cancer cells implicate LINK - A and LINK - A interacting kinases and receptors as promising therapeutic targets for TNBC.»
Not exact matches
Today, Rudensky, a Howard Hughes Medical Institute Investigator and professor of immunology at Sloan - Kettering Institute in New York City, counts among the world's foremost immunologists for his discoveries
on the molecular architecture of a type of immune
cell implicated in autoimmune disorders, inflammatory disease, and
cancer.
My research focuses
on the evolution, physiology and biochemistry of alpha crystallins, a group of small heat shock proteins that protect
cells against stress and are
implicated in numerous diseases such as lens cataracts, Parkinsons, Alzheimers and
cancer.